Multiple Myeloma: How Far Have We Come?
- 31 January 2003
- journal article
- editorial
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 78 (1) , 15-17
- https://doi.org/10.4065/78.1.15
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Review of 1027 Patients With Newly Diagnosed Multiple MyelomaMayo Clinic Proceedings, 2003
- Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arraysOncogene, 2002
- A molecular compendium of genes expressed in multiple myelomaBlood, 2002
- American Society of Clinical Oncology Clinical Practice Guidelines: The Role of Bisphosphonates in Multiple MyelomaJournal of Clinical Oncology, 2002
- Solitary bone plasmacytoma and extramedullary plasmacytomaCurrent Treatment Options in Oncology, 2002
- Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cellsBlood, 2002
- A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined SignificanceNew England Journal of Medicine, 2002
- Survival of multiple myeloma patients who are potential candidates for early high-dose therapy intensification/ autotransplantation and who were conventionally treated.Journal of Clinical Oncology, 1996
- Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials.Journal of Clinical Oncology, 1992
- Erythropoietin Treatment of Anemia Associated with Multiple MyelomaNew England Journal of Medicine, 1990